Enhanced procoagulatory activity, hyaline membrane formation and surfactant impairment in baboon bronchoalveolar lavage fluid: Studies on a new model combining acid aspiration and oleic acid infusion

Applied Cardiopulmonary Pathophysiology

Volumn 7, Issue 1, 1997, Pages 23-31

  Schlag, Günther ^a   Strohmaier, Wolfgang ^a   Redl, Heinz ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

Coagulation; Fibrinolysis; Hyaline membrane; Lung injury; Pulmonary surfactant; Surface tension

Indexed keywords

ALBUMIN; ANTITHROMBIN; D DIMER; ELASTASE; FIBRIN; HYALIN; INTERLEUKIN 6; LUNG SURFACTANT; OLEIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION PNEUMONIA; BABOON; BREATHING PATTERN; FIBRIN DEPOSITION; FIBRINOLYSIS; HEMODYNAMICS; HYALINE MEMBRANE DISEASE; HYPERCOAGULABILITY; HYSTERESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS; LUNG LAVAGE; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL;

EID: 0031407917     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Petty TL, Silvers GW, Paul GW, Stanford RE. Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 1979; 75: 571-1.
2. Hopewell PC, Murray J. The adult respiratory distress syndrome. In: Shibel EM, Moser KM (eds) Respiratory Emergencies. St. Louis, MO: Mosby, 1977, 101-6.
3. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; ii: 319-23.
4. Strohmaier W, Schlag G. Experimental models in surfactant research. In: Schlag G, Redl H (eds) Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin, Heidelberg: Springer-Verlag, 1993,757-71.
5. Holm BA. Surfactant inactivation in adult respiratory distress syndrome. In: Robertson B, van Golde LMG, Batenburg JJ (eds) Pulmonary Surfactant from Molecular Biology to Clinical Practice. Amsterdam: Elsevier, 1992, 665-84.
6. Seeger W, Stöhr G, Wolfe HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-38.
7. Hawgood S. The hydrophilic surfactant protein SP-A: molecular biology, structure and function. In: Robertson B, van Golde LMG, Batenburg JJ (eds) Pulmonary Surfactant from Molecular Biology to Clinical Practice. Amsterdam: Elsevier, 1992, 33-54.
8. Whitsett JA, Baatz JE. Hydrophobie surfactant proteins SP-B and SP-C: molecular biology, structure and function. In: Robcrtson B, van Golde LMG, Batenhurg JJ (eds) Pulmonary Surfactanl from Molecular Biology and to Clinical Practice. Amsterdam: Elsevier, 1992, 55-75.
9. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA. Reed CR, Fowler AAI, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-81.
10. Chapman HA, Stahl M, Allen CL, Yee R, Faiar DS. Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung. Am Rev Respir Dis 1988; 137: 1417-25.
11. Chapman HA, Alien CL, Stone OL. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 1985; 75: 2030-7.
12. Idell S, James KK, Coalson JJ. Fibrinolytic activity in bronchoalveolar lavage of baboon with diffuse alveolar damage: trends in two forms of lung injury. Crit Care Med 1992; 20: 1431-9.
13. Holm BA, Keicher L, Liu M, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J ApplPhysiol 1991; 71: 1-5.
14. Gilliard N, Heldll G, Loredo S, Gasser H, Redl H, Merritt TA, Spragg RG. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension porperties. J Clin Invest 1994; 93: 2608-15.
15. Pison U, Tam E, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated protein by neutrophil elastase. Biochim Biophys Acta 1989; 992: 251-7.
16. Strohmaier W, Redl H, Schlag G. Studies of the potential role of a semisynthetic surfactant preparation in an experimental aspiration trauma in rabbit. Exp Lung Res 1990; 16: 101-10.
17. Schlag G, Redl H, Czech K. Das Ölsäure-induzierte interstitielle Lungenödem am Hund: Vergleich der PEEP- mit einer Hochfrequenz-Jet-iiberlagerten ZEEP-Beatmung. Anaesthesist 1985; 34: 65-71.
18. Newald J, Davies J, Schlag G. Closed loop control of pentobarbital anesthesia in baboons. Circ Shock 1989; 27: 321.
19. Engelberts I, Möller A, Schoen GJM, Van der Linden CJ, Buurman WA. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991; 10: 69-76.
20. Seeger W, Hiibel J, Klapettek K, Pison U, Obertacke U, Joka T, Roka L. Procoagulant activity in bronchoalveolar lavage of severely traumatized patients: relation to the development of acute respiratory distress. Thromb Res 1991; 61: 53-64.
21. Van der Poll T, Levi M, Hack CE, Ten Cale H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-9.
22. Levi M, Van der Poll T, Biemond BJ, Ten Gate H, Kuipers B, Ten Cate JW. TNF-dependent bronchoalveolar activation of coagulation and depression of fibrinolysis as pathogenetic mechanism of ARDS in experimental endotoxemia in chimpanzees. Eur Cytokine Netw 1996; 7: 263.
23. Holm BA, Notier RH, Siegle JC, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985; 59: 1402-9.
24. Müller B, von Wiehert P. Differences of in vivo and in vitro exposure of rat surfactant apoprotein (SP-A) to nitrogen dioxide. Am Rev Respir Dis 1992; 145: A877.
25. Fuchs-Buder T, deMoerloose P, Ricou B, Reber G, Vifian C, Nicod L, Romand J-A, Suter PM. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir CritCareMed 1996; 153: 163-7.
26. Schuster DP. What is the mortality of ARDS? In: Vincent JL (ed.) Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg: Springer-Verlag, 1995,59-68.
27. Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai G-Z, Hite RD. Smith RM. Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-15.
28. Specr CP. Götze B, Curstcdt T, Rüberlson B. Phagocytic functions and TNF secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediat Res 1990; 28: 281.